Treos Bio Names Group of Leading Clinical and Regulatory Experts to Clinical Advisory Board
April 25, 2017 08:15 ET
|
Treos Bio Limited
SAN FRANCISCO, CA and LONDON, UNITED KINGDOM--(Marketwired - Apr 25, 2017) - Treos Bio, which is developing precision therapeutic cancer vaccines as well as companion diagnostics, today announced...
Treos Bio Announces Filing of Key Patent Applications on its Precision Therapeutic Cancer Vaccine Development Platform and its Compositions for Colorectal and Breast Cancers
April 03, 2017 11:49 ET
|
Treos Bio Limited
SAN FRANCISCO, CA and LONDON, UNITED KINGDOM--(Marketwired - Apr 3, 2017) - Treos Bio, which is developing precision therapeutic cancer vaccines coupled with companion diagnostics, today announced...
Precision Therapeutic Cancer Vaccine Developer Treos Bio Opens U.S. Headquarters in San Francisco
March 21, 2017 08:15 ET
|
Treos Bio Limited
SAN FRANCISCO, CA and LONDON, UNITED KINGDOM--(Marketwired - Mar 21, 2017) - Treos Bio Limited, which is developing precision therapeutic cancer vaccines coupled with companion diagnostics, today...
Treos Bio Raises $8 Million in Private Investment Round
February 13, 2017 08:15 ET
|
Treos Bio, Ltd.
SAN FRANCISCO, CA and LONDON, UNITED KINGDOM--(Marketwired - Feb 13, 2017) - Treos Bio, Ltd., which is developing precision cancer immunotherapies paired to companion diagnostics, today...
Treos Bio, Developer of Precision Cancer Vaccines, Emerges From Stealth
June 02, 2016 08:17 ET
|
Treos Bio, Inc.
BETHESDA, MD--(Marketwired - Jun 2, 2016) - Treos Bio, Inc., which is developing precision cancer vaccines paired to companion diagnostics, emerged from stealth mode today and announced the...